Faculty

Dr. Bastian is Professor of Internal Medicine and Chief of General Internal Medicine for the VA Connecticut Healthcare System. She is also Director of the Pain Research, Informatics, Multimorbidities, and Education (PRIME) Center, an interdisciplinary group that studies the complex interactions between pain and associated chronic disease and behavioral health factors, and develops and implements efficacious interventions to reduce unnecessary pain and suffering and overall disease burden. Her interests are in clinical decision support, women’s health, and smoking cessation.

Dr. Brandt is Professor of Emergency Medicine, Biostatistics and Anesthesiology, and Director of the Yale Center for Medical Informatics, and Division of Health Informatics. Dr. Brandt is trained and certified in preventive medicine, and completed a fellowship sponsored by the National Library of Medicine. Her research focuses on issues related to the design, development and implementation of informatics tools to enhance care concordant with practice guidelines, women’s health, and health informatics at the VA System.

Dr. Chaudhry is Associate Professor of Medicine (General Internal Medicine) and Director of the Yale Center for Healthcare Innovation, Redesign, and Learning (CHIRAL). She is an alumna of the RWJ Clinical Scholars Program. She is conducting a large-scale observational study, SILVER-AMI, funded by NHLBI, of 3000 older patients with acute myocardial infarction. The goal of this study is to understand how non-traditional risk factors, such as frailty and cognitive impairment, impact outcomes of this population. As Director of the Academic Hospitalist Program, she conducts work to improve the safety and quality of care for hospitalized patients. CHIRAL, supported by AHRQ, is studying care transitions into, within, and out of the hospital setting. In addition, Dr. Chaudhry leads the new Healthcare Innovations track of the National Clinician Scholars Program, which may serve as a “pipeline” program for YSIS.

Dr. Chupp is Professor of Internal Medicine (Pulmonary) and Director of the Yale Center for Asthma and Airways Disease (YCAAD). YCAAD research focuses on understanding the mediators and mechanisms underlying the development of asthma and other airway diseases. Its goals are to understand the pathogenesis of asthma, develop novel clinical tests to enhance treatment, and ultimately develop novel treatments and potential cures. Dr. Chupp was part of a recent NHLBI strategic planning group for asthma research that recommended an enhanced focus on implementation research to improve adherence to practice guidelines and mitigate the effects of disparities in asthma prevalence and treatment. 

Dr. Cleary is the C-E.A. Winslow Professor in Epidemiology and Public Health and Dean of the Yale School of Public Health. He is also a member of the National Academy of Medicine. His research focuses on patient-centered care and quality.  He is the PI of the Consumer Assessment of Healthcare Providers and Systems (CAHPS IV), funded by AHRQ to develop survey protocols for collecting information from consumers regarding their health plans and services. He has worked extensively with the CMS CAHPS survey administered to Medicare beneficiaries. Dr. Cleary’s expertise in measuring patient satisfaction allows for mentoring opportunities for YSIS Scholars. Furthermore, as PI of the Meeting Community Needs across the Prevention Spectrum Prevention Research Center (PRC), Dr. Cleary can facilitate participation in community-based projects. His expertise in medical sociology, instrument development, and involvement in the patient-centered movements will be invaluable for Scholars performing original data collection. Dr. Cleary also has extensive experience in public and private partnerships to translate and disseminate research into practice.

Dr. Curtis is an Associate Professor of Internal Medicine and a cardiologist. Dr. Curtis directs the American College of Cardiology Analytic Center at Yale’s Center for Outcomes Research and Evaluation (CORE). He led the development of registry-based outcome measures for CMS examining 30-day mortality following percutaneous coronary intervention (PCI) and ICD, and currently oversees maintenance of registry measures, contributes to the development of measures, and assists in developing approaches to cardiovascular surveillance. Currently, he is conducting a mixed methods research study of hospitals that perform PCI. The study includes a qualitative component in which top performing hospitals will be visited to identify candidate strategies, and will then move to a quantitative survey of PCI hospitals to determine which strategies are most closely associated with better patient outcomes. 

Dr. D’Onofrio is Professor and Chair of Emergency Medicine at the Yale. She is internationally known for her work in screening ED patients for alcohol and other drug use, brief intervention, and referral to treatment (SBIRT). She has received multiple R01s and a U01 from SAMHSA that trains residents in all primary care specialties in SBIRT. Dr. D’Onofrio is an investigator on the NHLBI-supported VIRGO trial that is studying the epidemiology of young women with heart attacks, enrolling at over 100 sites. 

Dr. Davis is Associate Professor of Public Health (Epidemiology of Microbial Diseases) and Medicine (Pulmonary, Critical Care, Sleep Medicine) at Yale. His research is based in Uganda and uses translational methods to improve TB diagnosis and evaluation in high-burden, resource-constrained settings. Ongoing projects span two general areas: 1) identifying TB biomarkers for diagnosis and monitoring, and 2) using implementation science to improve TB case finding and linkage to care. Training and capacity-building are a core aspect of all research activities, and a focus of the Fogarty Pulmonary Complications of AIDS Research Training Program at Makerere University and Walimu (www.walimu.org), a non-profit that uses implementation science to improve care of severe acute illness in Uganda.

Dr. Desai is an Associate Professor of Epidemiology at the Yale School of Public Health. As a core faculty member in the Yale National Clinician Scholars Program, he coordinates the “Clinical and Health Services Research Methods” course and teaching the quantitative methods portion of the curriculum. His research interests focus on improving the quality and outcomes of care in complex and vulnerable populations, including persons with mental disorders, veterans, immigrants, and the elderly. At CORE, Dr. Desai collaborates with a multidisciplinary team of investigators, under contract with CMS, to develop statistical models that are used to measure and publicly report hospital clinical outcomes using Medicare administrative data.

Dr. Dziura is Professor of Emergency Medicine, Internal Medicine, Public Health, and Deputy Director of the Yale Center for Analytical Sciences.He has co-authored over 200 peer-reviewed articles with many Yale investigators, including Dr. Bernstein and many YSIS mentors. He has been active in training young investigators, both individually (as a mentor and statistical resource) and in classroom settings (where he developed a graduate-level course on biostatistics). His primary interests are in the impact of obesity on youth, and the design and analysis of longitudinal studies, including clinical trials. 

Dr. Evans is Associate Professor of Emergency Medicine and the Director of the Yale Center for Medical Simulation. Her research focuses on the transfer of clinical skills from the simulation laboratory to the hospital setting. Her focus has been on central venous catheter insertion performance by resident physicians. She was the first to demonstrate fewer real-world complications from central line insertion performed by residents trained in the simulation laboratory. She is currently investigating decay in procedural skills.

Dr. Fiellin has focused his scholarly work on the interface between primary care, HIV and addiction. He is a primary care internist Board Certified in Internal Medicine and Addiction Medicine.  He serves as the inaugural Director of the Yale Program in Addiction Medicine. He conducts research on the transfer of treatment strategies, including opioid agonist maintenance with methadone and buprenorphine, from specialized settings to office-based, primary care, Emergency Department and HIV specialty settings. He has served as Principal Investigator on multiple NIH-funded trials and directed the SAMHSA Physician Clinical Support System for buprenorphine. He is the Director of the Community Research and Implementation Core at Yale's Center for Interdisciplinary Research on AIDS. He has received awards including the Nyswander/Dole Award from the American Association for the Treatment of Opioid Dependence, the 2008 Annual Award from the American Society of Addiction Medicine, the Excellence in Mentorship Award from AMERSA and the Dan Anderson Research Award from the Hazelden-Betty Ford Foundation. He has served on the White House Office of National Drug Control Policy (ONDCP), Drug Control Research, Data, and Evaluation Advisory Committee, and the World Health Organization and United Nations Office on Drugs and Crime Technical Guideline Development Group for psychosocially assisted pharmacologic treatment of opioid dependence. He served as Chair of the Center for Substance Abuse Treatment's, Treatment Improvement Protocol on Treatment of Viral Hepatitis in Patients with Substance Use Disorders and

on the Editorial Boards of Substance Abuse and the Journal of Addiction Medicine and is Co-Editor of Alcohol, Other Drugs & Health: Current Evidence and the Principles of Addiction Medicine, 4th, 5th and 6th Edition. He has served on the Board of Directors of the College on Problems of Drug Dependence and as Co-Chair of the Substance Abuse Task Force for the Society of General Internal Medicine.

Dr. Lynn Fiellin is recognized for excellence and leadership in clinical research and as a leader and innovator at YSM as founder/director of both the play2PREVENT (p2P) Lab at the Yale Center for Health & Learning Games and the ForAGirl summer program. She has also distinguished herself with her hospital leadership role as Fitkin Firm Chief at Yale New Haven Hospital as well as in a national role as a Founding Member of TIME'S UP Healthcare, a national organization focused on ensuring safe and equitable work places for women in healthcare. She has excelled as an educator, mentor, and role model in these programs.

Dr. Fiellin has created programs that specifically target impact on youth and young adults, on a local/community and national/international level. In the p2P Lab she established a premiere videogames research program of collaborating researchers, game developers, and community partners who develop and evaluate video game interventions targeting HIV prevention and smoking prevention in adolescents. She has received National Institutes of Health, foundation, and industry funding to build this lab. Dr. Fiellin's program has garnered considerable interest from students and trainees. Because of this interest and given her focus on supporting and promoting the personal and professional growth of girls and women, she created For A Girl, a summer program housed in her lab. There is a well-documented failure to attract girls and young women to the fields of science, technology, engineering, and math (STEM). Dr. Fiellin established ForAGirl as a novel, multifaceted program that focuses on promoting girls' engagement in STEM, medicine, and research. In addition to these innovative programs, she has focused on mentoring women trainees and faculty as a critical aspect of her work.

Dr. Grey is the Dean Emerita and Annie W. Goodrich Professor at the Yale School of Nursing. A pediatric nurse practitioner, Dr. Grey’s research has focused on the study of behavioral interventions that improve metabolic control of diabetes and the quality of life in young people and their parents, as well as the prevention of type 2 diabetes in high-risk youth. She has been instrumental in the development of practice-based research networks in nursing. Recent work has focused on the implementation of a school-based program for obesity prevention. 

Dr. Gross is a Professor in the Department of Medicine and Director of the NCSP. His research has focused on cancer in vulnerable populations, with a particular emphasis on clinical trial participation and the impact of chronic illness on cancer care and outcomes. He has received NIH grants to use the SEER-Medicare dataset to explore barriers to trial enrollment as well as the impact of non-cancer illnesses on older cancer patients. He partners with other investigators at Yale on implementation studies related to use of diagnostic imaging in renal colic, cancer, and other conditions. Dr. Gross also works with Dr. Krumholz on the Yale Open Data Access Project, which seeks to make clinical trial data widely available to investigators. 

Dr. Hendrickson is Associate Professor of Laboratory Medicine and Pediatrics, the Associate Director of the Transfusion Service at Yale-New Haven Hospital, and the Medical Director of the Apheresis Service at Yale-New Haven Hospital. She studies complications of transfusion therapy, particularly that of antibody formation. In addition to developing strategies to prevent RBC alloimmunization, she also works on the REDS-III study to identify strategies to implement safer transfusion practices nationwide. She is a member of the Yale Cooperative Center for Excellence in Hematology, a multi-center collaborative that uses emerging technologies to better understand diseases of the blood. 

Dr. Hsiao is Associate Professor of Pediatrics and of Emergency Medicine at Yale, and the Chief Medical Information Officer for the Yale School of Medicine and Yale-New Haven Health System. Allen also co-directs the Informatics Core for the Yale Center for Clinical Investigation, leading a team of physician informaticians, data scientists and analysts to support clinical care, operations, and research for the System and School. He led the successful implementation of the Epic electronic health record (EHR) system across the Yale healthcare enterprise, and has worked with numerous faculty to leverage the use of the EHR for improved clinical and research care. Current work and interests include directly engaging patients in research using the patient portal (MyChart), creation of a Hadoop-powered data lake (Baikal) and developing a comprehensive computational health data platform on it.  Additional interests include the use of mobile health technologies to enhance patient access to their own records, natural language processing, telemedicine, as well as the delivery of advanced decision support at the bedside.

Harlan Krumholz is a cardiologist and health care researcher at Yale University and Yale New Haven Hospital. He received a BS from Yale, an MD from Harvard Medical School, and a Masters in Health Policy and Management from the Harvard University School of Public Health. He is the Harold H. Hines, Jr. Professor of Medicine and Director of the Yale Center for Outcomes Research and Evaluation (CORE), one of the nation’s first and most productive research units dedicated to producing innovations to improve patient outcomes and promote better population health. He is also a Director of the Robert Wood Johnson Foundation Clinical Scholars Program, which prepares talented physicians to become future health care leaders.

Dr. Krumholz has been honored by membership in the Institute of Medicine, the Association of American Physicians, and the American Society for Clinical Investigation. He was named a Distinguished Scientist of the American Heart Association. He was elected to the Board of Trustees of the American College of Cardiology and the Board of Directors of the American Board of Internal Medicine, and was appointed by the U.S. government to the Board of Governors of the Patient-Centered Outcomes Research Institute. He is a 2014 recipient of the Friendship Award from the People’s Republic of China in recognition of his collaborative efforts to develop a national cardiovascular research network.

Dr. Krumholz is the editor of Circulation: Cardiovascular Quality and Outcomes, and editor of CardioExchange, a social media site of the publisher of the New England Journal of Medicine. He has published more than 800 articles and is the author of two books, one on smoking cessation and another on reducing the risk of heart disease. He has a regular blog on Forbes.com and has contributed to the New York Times Wellness blog, the New York Times op-ed page, and National Public Radio Shots blog.

Dr. Kryger is Professor of Internal Medicine (Pulmonary) and Clinical Professor of Nursing. His research has had a strong impact on clinical practice. He was the first to show the feasibility of using noninvasive techniques to ventilate people with post-polio syndrome in their homes. He reported the first use of computers in analyzing sleep breathing patterns and validated techniques of monitoring in which diagnostic data as well as therapeutic data on CPAP is obtained during the same night. His research programs obtained funding from government and industry sources from Canada, France, and the U.S. He is the author of practice guidelines addressing sleep, and the editor of two standard texts of sleep medicine.

Dr. Lampert is Professor of Internal Medicine (Cardiology) and an electrophysiologist. Her research foci include the links between psychological stress and sudden cardiac death, and the use of heart rate variability to measure acute and chronic stress. A newer line of investigation involves developing and disseminating criteria for termination of implantable defibrillator (AICD) function in individuals with limited life expectancy. Dr. Lampert first-authored guidelines for the Heart Rhythm Society on the termination of AICD function, and is now studying the impact on practice of those guidelines.